MAKO Surgical (Nasdaq: MAKO) reported earnings on May 7. Here are the numbers you need to know.

The 10-second takeaway
 For the quarter ended March 31 (Q1), MAKO Surgical beat slightly on revenues and missed expectations on earnings per share.

Compared to the prior-year quarter, revenue expanded significantly. GAAP loss per share dropped.

Margins increased across the board.

Revenue details
 MAKO Surgical booked revenue of $24.8 million. The nine analysts polled by S&P Capital IQ predicted a top line of $24.4 million on the same basis. GAAP reported sales were 26% higher than the prior-year quarter's $19.6 million.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
 EPS came in at -$0.21. The 10 earnings estimates compiled by S&P Capital IQ predicted -$0.19 per share. GAAP EPS were -$0.21 for Q1 against -$0.28 per share for the prior-year quarter.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Margin details
 For the quarter, gross margin was 73.6%, 150 basis points better than the prior-year quarter. Operating margin was -36.0%, much better than the prior-year quarter. Net margin was -38.8%, much better than the prior-year quarter. (Margins calculated in GAAP terms.)

Looking ahead
 Next quarter's average estimate for revenue is $28.7 million. On the bottom line, the average EPS estimate is -$0.27.

Next year's average estimate for revenue is $126.0 million. The average EPS estimate is -$0.65.

Investor sentiment
 The stock has a five-star rating (out of five) at Motley Fool CAPS, with 1,201 members out of 1,246 rating the stock outperform, and 45 members rating it underperform. Among 266 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 255 give MAKO Surgical a green thumbs-up, and 11 give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on MAKO Surgical is hold, with an average price target of $14.57.

Is MAKO Surgical the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.